Article
The genetic architecture of methotrexate toxicity is similar in Drosophila melanogaster and humans.
G3 (Bethesda, Md.) - 7 Aug 2013
Kislukhin Galina, King Elizabeth G, Walters Kelli N, Macdonald Stuart J, Long Anthony D
Abstract excerpt
The severity of the toxic side effects of chemotherapy varies among patients, and much of this variation is likely genetically based. Here, we use the model system Drosophila melanogaster to genetically dissect the toxicity of methotrexate (MTX), a drug used primarily to treat childhood acute lym...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
